Adjuvant therapies for cancer
The department of oncology has expertise in all types of gastrointestinal cancer, with particular interests in primary and secondary liver and biliary cancers. This is backed by an extensive research programme of clinical trials and laboratory research to develop new treatments and better ways of imaging and monitoring these cancers. This is supported by the UCL Experimental Cancer Medicine Centre and major research grants from Cancer Research UK and the National Institute for Health Research, as well as by national and international research collaborations.
The royal free radiotherapy department hosts a multiprofessional team which encompasses the work of the clinicians, radiographers, radiotherapy review specialists, radiotherapy physicists and technologists. The department is a tertiary referral centre for the provision of specialist cancer services, providing radiotherapy services to a wide sector of London, as well as to private patients worldwide.
The department provides both palliative and radical cancer treatments. All treatments are CT planned and most radical treatments are undertaken with a 3D/conformal treatment plan.
The department uses a range of equipment to plan and deliver accurate and safe radiotherapy treatment to patients. This includes an AcQSim CT simulator and twinned dual-energy 6MV and 10MV Varian 2100CD linear accelerators installed just two years ago, with a 120-leaf integral multi leaf collimator, with a-Si KV portal imaging system, with gating facility, with cone beam, and with electron beam facility.
For more information about the adjuvant therapies for cancer offered at the Royal Free Private Patients Unit, please call or email on:
Tel: 020 7317 7751